4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-006391
Chief Scientific Officer sold 21,028 shares at an average $18.39 ($386,743)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Russell Alan J Chief Scientific Officer | 2021-10-06 | Sale | −2,108 | $18.03 | $38,007 | 171,214 | D: show line 1 in the form |
| Russell Alan J Chief Scientific Officer | 2021-10-07 | Sale | −13,018 | $18.56 | $241,614 | 158,196 | D: show line 2 in the form |
| Russell Alan J Chief Scientific Officer | 2021-10-08 | Sale | −5,902 | $18.15 | $107,121 | 152,294 | D: show line 3 in the form |
| Open-market sales · 21,028 sh · avg $18.39 · $386,743 | |||||||
Loading xslF345X03/primarydocument.xml…